AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34352145 — intervention group
Group type: COMPARATOR
Intervention: Dome abutment (Group A)
Number of subjects: 12
Study 34352145 — intervention group
Group type: EXPERIMENTAL
Intervention: Both abutments
Number of subjects: 12
Study 33105357 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative neuromuscular training (INT) warm-up (n = 97)
Number of subjects: 190
Study 33105357 — intervention group
Group type: COMPARATOR
Intervention: Conventional warm-up (n = 93)
Number of subjects: 190
Study 616522947 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation (25-mg agomelatine)
Number of subjects: 60
Study 616522947 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation (25-mg agomelatine)
Number of subjects: 60
Study 616522947 — intervention group
Group type: EXPERIMENTAL
Intervention: Test and Reference formulations
Number of subjects: 60
Study 35075225 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound imaging group (n=15)
Number of subjects: 29
Study 35075225 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=14)
Number of subjects: 29
Study 33619550 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab plus trastuzumab and standard chemotherapy
Number of subjects: 0
Study 33619550 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus trastuzumab and standard chemotherapy
Number of subjects: 0
Study 32228427 — intervention group
Group type: EXPERIMENTAL
Intervention: Chamomile oil inhalation
Number of subjects: 128
Study 32228427 — intervention group
Group type: COMPARATOR
Intervention: Placebo inhalation
Number of subjects: 128
Study 34927554 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity and Ergonomics Improvement Program (PAEIP)
Number of subjects: 120
Study 34927554 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 34164829 — intervention group
Group type: EXPERIMENTAL
Intervention: QS‐Nd:YAG toning
Number of subjects: 30
Study 34164829 — intervention group
Group type: COMPARATOR
Intervention: Low power fractional CO2 laser alone
Number of subjects: 30
Study 34164829 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined QS‐Nd:YAG toning with low power fractional CO2
Number of subjects: 30
Study 32199656 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate 50 mg/kg
Number of subjects: 68
Study 32199656 — intervention group
Group type: COMPARATOR
Intervention: Rocuronium 1 mg/kg
Number of subjects: 68
Study 35481889 — intervention group
Group type: EXPERIMENTAL
Intervention: N-VAR (fixed exercises)
Number of subjects: 23
Study 35481889 — intervention group
Group type: COMPARATOR
Intervention: VAR (varied exercises)
Number of subjects: 23
Study 33480045 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine (NAC)
Number of subjects: 50
Study 33480045 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 32463774 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led comprehensive chemotherapy consultation services
Number of subjects: 96
Study 32463774 — intervention group
Group type: COMPARATOR
Intervention: Control group (historical patients who received first cycle of chemotherapy)
Number of subjects: 96
Study 36108891 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus Ipilimumab
Number of subjects: 13
Study 36108891 — intervention group
Group type: COMPARATOR
Intervention: Nivolumab
Number of subjects: 13
Study 33091403 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma-rich growth factor (PRGF)
Number of subjects: 100
Study 33091403 — intervention group
Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 100
Study 32044751 — intervention group
Group type: EXPERIMENTAL
Intervention: Run4Love program via WeChat
Number of subjects: 300
Study 32044751 — intervention group
Group type: COMPARATOR
Intervention: Usual care and a brochure on nutrition for PLWH
Number of subjects: 300
Study 35727080 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Planning Counseling (intervention)
Number of subjects: 19155
Study 35727080 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal family planning counseling (intervention)
Number of subjects: 19155
Study 35727080 — intervention group
Group type: EXPERIMENTAL
Intervention: PPIUD-specific counseling (intervention)
Number of subjects: 19155
Study 35727080 — intervention group
Group type: EXPERIMENTAL
Intervention: Postnatal family planning counseling (spillover effect)
Number of subjects: 19155
Study 33774594 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (1g administered intravenously upon induction of anaesthesia)
Number of subjects: 93
Study 33774594 — intervention group
Group type: COMPARATOR
Intervention: Normal saline infusion (control)
Number of subjects: 93
Study 35959201 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-power visible-light-activated photodynamic therapy (PDT)
Number of subjects: 0
Study 35959201 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32867852 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) plus standard personal protective equipment (PPE) - 800mg loading dose on day of randomization (two 400mg doses 12 hours apart), followed by 400mg once a week for 12 weeks.
Number of subjects: 6950
Study 32867852 — intervention group
Group type: COMPARATOR
Intervention: Standard personal protective equipment (PPE) alone.
Number of subjects: 6950
Study 32867852 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) plus standard PPE.
Number of subjects: 6950
Study 36453309 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine eye drops
Number of subjects: 273
Study 36453309 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Van Herick grades (217 eyes)
Number of subjects: 273
Study 36453309 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow gonioscopy grades (238 eyes)
Number of subjects: 273
Study 36453309 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow OCT angle value (165 eyes)
Number of subjects: 273
Study 34884230 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise
Number of subjects: 69
Study 34884230 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric exercise
Number of subjects: 69
Study 34884230 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric exercise
Number of subjects: 69
Study 34884230 — intervention group
Group type: COMPARATOR
Intervention: No exercise (Control)
Number of subjects: 69
Study 33955162 — intervention group
Group type: EXPERIMENTAL
Intervention: 105 mg edaravone oral suspension
Number of subjects: 42
Study 33955162 — intervention group
Group type: COMPARATOR
Intervention: 60 mg intravenous edaravone
Number of subjects: 42
Study 33955162 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 42
Study 33087177 — intervention group
Group type: EXPERIMENTAL
Intervention: People with obesity (PwO)
Number of subjects: 750
Study 33087177 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians
Number of subjects: 750
Study 33087177 — intervention group
Group type: EXPERIMENTAL
Intervention: People with obesity (PwO) and physicians
Number of subjects: 750
Study 33087177 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare professionals (HCPs)
Number of subjects: 750
Study 33087177 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietitians
Number of subjects: 750
Study 35683988 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutri-Score (N-S)
Number of subjects: 4530
Study 35683988 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Traffic Lights (MTL)
Number of subjects: 4530
Study 35683988 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning Label (WL)
Number of subjects: 4530
Study 35683988 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Choice tick (PC)
Number of subjects: 4530
Study 35683988 — intervention group
Group type: COMPARATOR
Intervention: no-label control
Number of subjects: 4530
Study 35683988 — intervention group
Group type: EXPERIMENTAL
Intervention: N-S, MTL, WL
Number of subjects: 4530
Study 32321450 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate
Number of subjects: 150
Study 32321450 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium-potassium citrate
Number of subjects: 150
Study 32321450 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy group without any alkalinizing agents
Number of subjects: 150
Study 32321450 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate, Sodium-potassium citrate, Standard therapy
Number of subjects: 150
Study 36379437 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol Telemedicine Consult (ATC) Service, including alcohol pharmacotherapy and SBIRT delivered by clinical pharmacists
Number of subjects: 0
Study 36379437 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC) arm providing systematic alcohol SBIRT
Number of subjects: 0
Study 32034673 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive evaluation via a chest pain unit (CPU) for patients ≥ 65 years
Number of subjects: 1220
Study 32034673 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive evaluation via a chest pain unit (CPU) for patients < 65 years
Number of subjects: 1220
Study 35042448 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose combination of amlodipine 5 mg plus bisoprolol 5 mg
Number of subjects: 439
Study 35042448 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 10 mg
Number of subjects: 439
Study 32707579 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised moderate-to-high-intensity progressive resistance training
Number of subjects: 32
Study 32707579 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based resistance training
Number of subjects: 32
Study 32707579 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 35844443 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative family nursing interventions
Number of subjects: 144
Study 35844443 — intervention group
Group type: COMPARATOR
Intervention: Nursing interventions including health education, psychological intervention, medication guidance, complication prevention, and follow-up management
Number of subjects: 144
Study 33277124 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperspectral imaging (HSI) for fat quantification in shelled beans
Number of subjects: 170
Study 33277124 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperspectral imaging (HSI) for fat quantification in in‐shell beans
Number of subjects: 170
Study 33277124 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual segregation of beans
Number of subjects: 170
Study 32078379 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-Directed Interaction - Toddler (CDI-T)
Number of subjects: 66
Study 32078379 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 66
Study 34674258 — intervention group
Group type: EXPERIMENTAL
Intervention: Letermovir
Number of subjects: 0
Study 34674258 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34154795 — intervention group
Group type: EXPERIMENTAL
Intervention: Cidofovir
Number of subjects: 16
Study 34154795 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 16
Study 34154795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 34154795 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 16
Study 32011402 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilt-Down (TD) positioning
Number of subjects: 150
Study 32011402 — intervention group
Group type: COMPARATOR
Intervention: Left Lateral (LL) positioning
Number of subjects: 150
Study 36196400 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric isokinetic training
Number of subjects: 30
Study 36196400 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric isokinetic training
Number of subjects: 30
Study 36196400 — intervention group
Group type: COMPARATOR
Intervention: Between-group analysis
Number of subjects: 30
Study 35190439 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning-based patient decision aid (PDA) integrating patient-reported outcomes and clinical variables.
Number of subjects: 200
Study 35190439 — intervention group
Group type: COMPARATOR
Intervention: Patient-reported outcomes (PROMs) and shared decision-making (SDM) process.
Number of subjects: 200
Study 33066081 — intervention group
Group type: EXPERIMENTAL
Intervention: n‐3 PUFA‐enriched hen eggs (two eggs per day, for three weeks, total of approximately 407 mg/day n‐3 PUFAs)
Number of subjects: 20
Study 33066081 — intervention group
Group type: COMPARATOR
Intervention: Regular eggs (two eggs per day for three weeks, total of approximately 75 mg/day n‐3 PUFAs)
Number of subjects: 20
Study 35109598 — intervention group
Group type: EXPERIMENTAL
Intervention: Video conferencing telehealth (n=30)
Number of subjects: 60
Study 35109598 — intervention group
Group type: COMPARATOR
Intervention: Telephone-only telehealth (n=30)
Number of subjects: 60
Study 32203892 — intervention group
Group type: EXPERIMENTAL
Intervention: CGX 1 g
Number of subjects: 67
Study 32203892 — intervention group
Group type: EXPERIMENTAL
Intervention: CGX 2 g
Number of subjects: 67
Study 32203892 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 32203892 — intervention group
Group type: EXPERIMENTAL
Intervention: CGX 1 g (without antiviral use)
Number of subjects: 67
Study 35439567 — intervention group
Group type: COMPARATOR
Intervention: Semaglutide 2.4 mg once weekly
Number of subjects: 108
Study 35439567 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide plus cilofexor 30 mg
Number of subjects: 108
Study 35439567 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide plus cilofexor 100 mg
Number of subjects: 108
Study 35439567 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide plus firsocostat 20 mg
Number of subjects: 108
Study 35439567 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide, cilofexor 30 mg and firsocostat
Number of subjects: 108
Study 33499545 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated Exercise Program (GEP)
Number of subjects: 0
Study 33499545 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care exercise program
Number of subjects: 0
Study 36210793 — intervention group
Group type: EXPERIMENTAL
Intervention: Idiopathic uveitis
Number of subjects: 97
Study 36210793 — intervention group
Group type: EXPERIMENTAL
Intervention: Uveitis due to juvenile idiopathic arthritis (JIA)
Number of subjects: 97
Study 36210793 — intervention group
Group type: EXPERIMENTAL
Intervention: Uveitis due to Behçet's disease (BD)
Number of subjects: 97
Study 36210793 — intervention group
Group type: COMPARATOR
Intervention: Complications related to uveitis
Number of subjects: 97
Study 33704466 — intervention group
Group type: EXPERIMENTAL
Intervention: OJ with 5 g fiber from OP (OPF)
Number of subjects: 62
Study 33704466 — intervention group
Group type: COMPARATOR
Intervention: Whole Orange Fruit (WOF)
Number of subjects: 62
Study 33704466 — intervention group
Group type: COMPARATOR
Intervention: OJ
Number of subjects: 62
Study 33536047 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of IV tranexamic acid (TXA) at admission
Number of subjects: 125
Study 33536047 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (NS)
Number of subjects: 125
Study 35112378 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous tanezumab (2.5–10 mg every 8 weeks)
Number of subjects: 0
Study 35112378 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tanezumab (2.5–20 mg every 8 weeks for up to 56 weeks)
Number of subjects: 0
Study 35112378 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment-emergent anti-drug antibodies (TE ADA)
Number of subjects: 0
Study 35112378 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline nerve growth factor (NGF)
Number of subjects: 0
Study 33012216 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein (PRO; 60 g/day)
Number of subjects: 40
Study 33012216 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate (CON)
Number of subjects: 40
Study 32912199 — intervention group
Group type: EXPERIMENTAL
Intervention: Job retention vocational rehabilitation (JRVR) plus a self-help written work advice pack and usual care
Number of subjects: 240
Study 32912199 — intervention group
Group type: COMPARATOR
Intervention: Self-help written work advice pack plus usual care
Number of subjects: 240
Study 35450050 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir + Tocilizumab
Number of subjects: 100
Study 35450050 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 100
Study 36368911 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video promoting paternal involvement in childcare
Number of subjects: 451
Study 36368911 — intervention group
Group type: COMPARATOR
Intervention: Educational video on the prevention of shaken baby syndrome (Control)
Number of subjects: 451
Study 33432157 — intervention group
Group type: EXPERIMENTAL
Intervention: Epo 1000 U/kg
Number of subjects: 628
Study 33432157 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 628
Study 33268476 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs (non-steroidal anti-inflammatory drugs) as a strong opioid adjunct
Number of subjects: 223
Study 33268476 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of NSAIDs
Number of subjects: 223
Study 33268476 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective COX-2 inhibitors and non-selective COX-2 inhibitors
Number of subjects: 223
Study 33268476 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 223
Study 33268476 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAIDs
Number of subjects: 223
Study 35889835 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed supplementation (28 g/day) for 10 weeks in group 1 (lean patients with severe dyslipidaemia)
Number of subjects: 22
Study 35889835 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed supplementation (28 g/day) for 10 weeks in group 2 (obese patients with mild dyslipidaemia)
Number of subjects: 22
Study 35889835 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed supplementation (28 g/day) for both groups
Number of subjects: 22
Study 35889835 — intervention group
Group type: COMPARATOR
Intervention: Ordinary diet + placebo in group 1
Number of subjects: 22
Study 35889835 — intervention group
Group type: COMPARATOR
Intervention: Ordinary diet in group 2
Number of subjects: 22
Study 33656480 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based education and navigation program
Number of subjects: 14
Study 32000141 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (95% of ventilatory threshold 2 for 1 hour)
Number of subjects: 18
Study 32000141 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (6 × 30-second intervals at 175% peak power output with 4.5-minute rest)
Number of subjects: 18
Study 32000141 — intervention group
Group type: EXPERIMENTAL
Intervention: RPE across endurance and high-intensity interval training sessions
Number of subjects: 18
Study 35685985 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 63
Study 35685985 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 63
Study 32790496 — intervention group
Group type: EXPERIMENTAL
Intervention: Maytenus ilicifolia extract (MIE)
Number of subjects: 10
Study 32790496 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 33725766 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocktail group
Number of subjects: 90
Study 33725766 — intervention group
Group type: EXPERIMENTAL
Intervention: TBBr group
Number of subjects: 90
Study 33725766 — intervention group
Group type: COMPARATOR
Intervention: BALF group
Number of subjects: 90
Study 35229253 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 130
Study 35229253 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 130
Study 33831843 — intervention group
Group type: EXPERIMENTAL
Intervention: intermittent warm-up + NaHCO3 (IWSB)
Number of subjects: 8
Study 33831843 — intervention group
Group type: COMPARATOR
Intervention: control warm-up + NaHCO3 (CWSB)
Number of subjects: 8
Study 33831843 — intervention group
Group type: EXPERIMENTAL
Intervention: intermittent warm-up + placebo
Number of subjects: 8
Study 33831843 — intervention group
Group type: COMPARATOR
Intervention: control warm-up + placebo (CWP)
Number of subjects: 8
Study 35027932 — intervention group
Group type: EXPERIMENTAL
Intervention: Low current intensity electroacupuncture (EA)
Number of subjects: 73
Study 35027932 — intervention group
Group type: EXPERIMENTAL
Intervention: High current intensity electroacupuncture (EA)
Number of subjects: 73
Study 35027932 — intervention group
Group type: COMPARATOR
Intervention: Loperamide (control)
Number of subjects: 73
Study 32421350 — intervention group
Group type: EXPERIMENTAL
Intervention: Endothelium-dependent dilation (EDD) in women
Number of subjects: 0
Study 32421350 — intervention group
Group type: EXPERIMENTAL
Intervention: Endothelium-independent dilation (EID) in younger men and women (<55 years)
Number of subjects: 0
Study 32421350 — intervention group
Group type: EXPERIMENTAL
Intervention: EDD and EID in younger women vs younger men
Number of subjects: 0
Study 32421350 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes impact on EID
Number of subjects: 0
Study 32421350 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure and cardiovascular disease impact on EDD and EID
Number of subjects: 0
Study 36069480 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant Surface Culture (ISC)
Number of subjects: 42
Study 36069480 — intervention group
Group type: COMPARATOR
Intervention: Standard Tissue Sampling Culture (TSC)
Number of subjects: 42
Study 36324867 — intervention group
Group type: EXPERIMENTAL
Intervention: PP-Script (pre-procedure script)
Number of subjects: 160
Study 36324867 — intervention group
Group type: COMPARATOR
Intervention: PX-Script (pre-extubation script)
Number of subjects: 160
Study 36324867 — intervention group
Group type: COMPARATOR
Intervention: Both PP-and PX-Scripts
Number of subjects: 160
Study 36324867 — intervention group
Group type: COMPARATOR
Intervention: No script read
Number of subjects: 160
Study 32699909 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (two cycles of methotrexate, doxorubicin, vinblastine, and cisplatin) followed by radical cystectomy
Number of subjects: 99
Study 32699909 — intervention group
Group type: COMPARATOR
Intervention: Radical cystectomy alone
Number of subjects: 99